Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06826014 · ClinicalTrials.gov registry record
TREC@TAMU Cancer Prevention Registry and Repository
A clinical trial of Cancer and Diet, sponsored by Texas A&M University.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT06826014: Recruiting study of Cancer and Diet, sponsored by Texas A&M University.
NCT06826014 is a study of Cancer and Diet that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 2,500 participants, below the 3,487-participant average among 615 other Cancer trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06826014, a study of Cancer and Diet, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study collects health and genetic information to implement cancer prevention and treatment strategies.
Primary Outcome
Measure the frequency and nature of adverse drug reactions by obtaining a complete medical history and physical examination and validating the patient's current concomitant medication list during the office visit. Patient medical information would be input into the ActX platform, which functions as a computable EHR medical record analysis, evaluation of polypharmacy status, and monitoring of ADRs using the Naranjo Scale will be conducted for the duration of the study.
Conditions Studied
Study Locations (1)
Texas
- Texas A&M Family Care - Bryan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2025-03 |
| Est. Completion | 2030-11 |
What NCT06826014 shows while recruiting
NCT06826014 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, below the 3,487-participant average among 615 other Cancer trials with a reported enrollment target (28% lower).
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06826014 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06826014 about?
NCT06826014 is a clinical study titled "TREC@TAMU Cancer Prevention Registry and Repository". This study collects health and genetic information to implement cancer prevention and treatment strategies.
What is the current status of trial NCT06826014?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2025-03. Estimated completion is 2030-11.
What conditions does trial NCT06826014 study?
This clinical trial studies the following conditions: Cancer, Diet, Lifestyle Factors, Genetics, Disease.
Who is sponsoring clinical trial NCT06826014?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06826014 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06826014's enrollment target sits among peer trials
2,500 54th of 615 higher than 562 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia